Lactate dehydrogenase type A (
LDH-A) is a key metabolic
enzyme catalyzing
pyruvate into
lactate and is excessively expressed by
tumor cells. Transforming growth factor-beta2 (TGF-beta2) is a key regulator of invasion in high-grade
gliomas, partially by inducing a mesenchymal phenotype and by remodeling the extracellular matrix. In this study, we tested the hypothesis that
lactate metabolism regulates TGF-beta2-mediated migration of
glioma cells.
Small interfering RNA directed against
LDH-A (siLDH-A) suppresses, and
lactate induces,
TGF-beta2 expression, suggesting that
lactate metabolism is strongly associated with
TGF-beta2 in
glioma cells. Here we demonstrate that
TGF-beta2 enhances expression, secretion, and activation of
matrix metalloproteinase-2 (MMP-2) and induces the cell surface expression of
integrin alpha(v)beta(3) receptors. In spheroid and Boyden chamber migration assays, inhibition of MMP-2 activity using a specific MMP-2 inhibitor and blocking of
integrin alpha(v)beta(3) abrogated
glioma cell migration stimulated by
TGF-beta2. Furthermore, siLDH-A inhibited MMP2 activity, leading to inhibition of
glioma migration. Taken together, we define an
LDH-A-induced and TGF-beta2-coordinated regulatory cascade of transcriptional regulation of MMP-2 and
integrin alpha(v)beta(3). This novel interaction between
lactate metabolism and
TGF-beta2 might constitute a crucial mechanism for
glioma migration.